Special Issue "Bioactivity-Focused Syntheses of Marine Natural Products and Congeners"

Quicklinks

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (28 February 2014)

Special Issue Editor

Guest Editor
Dr. Malcom McCulloch
Biomedical Research Centre, Sheffield Hallam University, City Campus, Howard Street, Sheffield, S1 1WB, UK
Website: http://www.shu.ac.uk/research/bmrc/sp_malcolm_mcculloch.html
E-Mail: m.mcculloch@shu.ac.uk
Phone: + 0114 225 6020
Interests: the natural origins of therapeutic drugs: natural product scaffolds

Special Issue Information

Dear Colleagues,

Marine natural products provide biologically-privileged frameworks for the discovery and development of new therapeutic drugs and biochemical tools. These development processes are frequently supported by synthetic chemistry, including total synthesis, semi-synthesis and congener synthesis. The roles played by synthesis and semi-synthesis include: (1) providing access to adequate quantities of compounds when natural supply is limited; and (2) providing novel analogues for biological evaluation (i.e. develop structure-activity relationships). These efforts can lead to more efficacious compounds, or simplified analogues that retain the desirable biological activity. This Special Issue of Marine Drugs focuses on the use of synthesis to support the discovery and development of marine natural products and congeners as drugs and biochemical tool compounds.

You are cordially invited to submit original papers and review articles to “Bioactivity-Focused Syntheses of Marine Natural Products and Congeners”. Papers describing biological screening of libraries of synthetic or semi-synthetic marine natural product derivatives are encouraged. Manuscripts describing total syntheses, semi-syntheses and analogue syntheses are most welcome provided they include some details of biological evaluations.

Dr Malcolm W. B. McCulloch
Guest Editor

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed Open Access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs).

Keywords

  • marine natural product
  • total synthesis
  • semi-synthesis
  • analogue synthesis
  • structure-activity relationships
  • bioactive natural product derivatives
  • bioactivity profiling
  • screening of synthetic and semi-synthetic compound libraries

Published Papers (6 papers)

Download All Papers
Sort by:
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-6
p. 4833-4850
by , , , , , , ,  and
Mar. Drugs 2014, 12(9), 4833-4850; doi:10.3390/md12094833
Received: 5 August 2014; in revised form: 25 August 2014 / Accepted: 5 September 2014 / Published: 19 September 2014
Show/Hide Abstract | PDF Full-text (989 KB) | HTML Full-text | XML Full-text | Supplementary Files
abstract graphic
p. 3138-3160
by ,  and
Mar. Drugs 2014, 12(6), 3138-3160; doi:10.3390/md12063138
Received: 10 April 2014; in revised form: 30 April 2014 / Accepted: 4 May 2014 / Published: 28 May 2014
Show/Hide Abstract | Cited by 2 | PDF Full-text (795 KB) | HTML Full-text | XML Full-text | Supplementary Files
abstract graphic
p. 1757-1772
by , , ,  and
Mar. Drugs 2014, 12(4), 1757-1772; doi:10.3390/md12041757
Received: 7 January 2014; in revised form: 6 February 2014 / Accepted: 27 February 2014 / Published: 27 March 2014
Show/Hide Abstract | PDF Full-text (697 KB) | HTML Full-text | XML Full-text | Supplementary Files
abstract graphic
p. 1715-1731
by , , , , , ,  and
Mar. Drugs 2014, 12(4), 1715-1731; doi:10.3390/md12041715
Received: 26 December 2013; in revised form: 24 February 2014 / Accepted: 26 February 2014 / Published: 25 March 2014
Show/Hide Abstract | PDF Full-text (928 KB) | HTML Full-text | XML Full-text | Supplementary Files
p. 940-963
by , , , , , , ,  and
Mar. Drugs 2014, 12(2), 940-963; doi:10.3390/md12020940
Received: 25 November 2013; in revised form: 17 January 2014 / Accepted: 23 January 2014 / Published: 14 February 2014
Show/Hide Abstract | Cited by 2 | PDF Full-text (939 KB) | HTML Full-text | XML Full-text | Supplementary Files
abstract graphic
p. 5159-5189
by , , , , , , , , , ,  and
Mar. Drugs 2013, 11(12), 5159-5189; doi:10.3390/md11125159
Received: 1 November 2013; in revised form: 2 December 2013 / Accepted: 4 December 2013 / Published: 18 December 2013
Show/Hide Abstract | PDF Full-text (1444 KB) | HTML Full-text | XML Full-text | Supplementary Files
abstract graphic
Select/unselect all
Displaying article 1-6
Select articles Export citation of selected articles as:

Last update: 31 July 2013

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert